Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GUARDANT HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)

11/05/2020 | 04:16pm EST
Item 2.02. Results of Operations and Financial Condition.
On November 5, 2020, Guardant Health, Inc. (the "Company") issued a press
release announcing certain financial results for the fiscal quarter ended
September 30, 2020. The full text of the press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information furnished in this Current Report on Form 8-K (including Exhibit
99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that Section, nor shall it be deemed to be incorporated by
reference into any filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.

Exhibit No. Description

     99.1               Press release of Guardant Health, Inc., dated     November 5    , 2020
      104             Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses

All news about GUARDANT HEALTH, INC.
08:12aGUARDANT HEALTH : Head-to-Head Study Shows Guardant360 Liquid Biopsy Outperforms..
BU
01/19GUARDANT HEALTH : to Partner With Vall d'Hebron Institute of Oncology to Set Up ..
MT
01/18GUARDANT HEALTH : and Vall d'Hebron Institute of Oncology Announce Partnership t..
BU
01/14GUARDANT HEALTH : to Present Data at ASCO Gastrointestinal Cancers Symposium Sho..
BU
01/11GUARDANT HEALTH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
01/11GUARDANT HEALTH : Stifel Starts Guardant Health at Buy With $175 Price Target
MT
01/07GUARDANT HEALTH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2020GUARDANT HEALTH : to Participate in the 39th Annual J.P. Morgan Healthcare Confe..
BU
2020GUARDANT HEALTH : AMEA Wins Frost & Sullivan's Market Leadership Award for Liqui..
AQ
2020Guardant Health Names Michael Bell as CFO
MT
More news
Financials (USD)
Sales 2020 285 M - -
Net income 2020 -218 M - -
Net cash 2020 1 305 M - -
P/E ratio 2020 -67,2x
Yield 2020 -
Capitalization 14 735 M 14 735 M -
EV / Sales 2020 47,1x
EV / Sales 2021 36,0x
Nbr of Employees 622
Free-Float 92,9%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 156,36 $
Last Close Price 147,39 $
Spread / Highest target 28,9%
Spread / Average Target 6,09%
Spread / Lowest Target -43,7%
EPS Revisions
Managers and Directors
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.14.36%14 987
EXACT SCIENCES CORPORATION3.29%22 430
BGI GENOMICS CO., LTD.31.71%9 670
INVITAE CORPORATION14.06%9 123
ADAPTIVE BIOTECHNOLOGIES CORPORATION-7.59%8 499
IOVANCE BIOTHERAPEUTICS, INC.-3.86%6 544